{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:03:12Z","timestamp":1780027392065,"version":"3.53.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Unit CFU 5029"},{"name":"Precision Medicine for Early-Onset Low Bone Mineral Density Disorders","award":["517063424"],"award-info":[{"award-number":["517063424"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pathogenic variants in IDUA, encoding \u03b1-L-iduronidase (IDUA), cause the autosomal recessive lysosomal storage disorder mucopolysaccharidosis type I (MPS I). Deficiency of \u03b1-L-iduronidase leads to the accumulation of partially degraded glycosaminoglycans in various tissues, including the musculoskeletal system. Clinically, typical skeletal manifestations are dysostosis multiplex, joint contractures, and low BMD. Mucopolysaccharidosis type I represents a spectrum of disease severity. Especially in attenuated disease, establishing an accurate diagnosis and initiating disease-specific therapy, including enzyme replacement therapy (ERT) and osteological treatment, is challenging. A 33-yr-old female patient presented with a history of juvenile idiopathic arthritis, persistent spinopelvic instability, and reduced BMD. Multiple surgical attempts to stabilize the spinopelvic nonunion had failed, thus osteological co-treatment with teriparatide to promote bone healing was recommended. Despite a significant BMD increase, spinopelvic nonunion persisted. Given the combination of short stature, joint contractures, and corneal clouding, a genetic skeletal dysplasia was suspected. Exome sequencing (ES) was inconclusive, whereas short-read genome sequencing (GS) revealed the combination of a 14\u00a0kb deletion and a promotor variant in IDUA. Thus, the diagnosis of MPS I in the attenuated form was made, and ERT was initiated. This case highlights the importance of considering MPS I in patients with short stature, joint contractures, skeletal dysplasia, and low BMD. Diagnosis can be overlooked in this attenuated form, underscoring the value of genetic testing, with GS offering advantages over ES. These findings emphasize the need for early diagnosis, systematic osteological evaluation, and individualized treatment strategies in patients with skeletal dysplasia.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag065","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:46:14Z","timestamp":1775648774000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed diagnosis of mucopolysaccharidosis type I in a patient with spinopelvic instability, short stature, and skeletal dysplasia"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7522-4887","authenticated-orcid":false,"given":"Oskar","family":"Windels","sequence":"first","affiliation":[{"name":"Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Lindschau","sequence":"additional","affiliation":[{"name":"International Center for Lysosomal Disorders (ICLD), Department of Pediatrics, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-9290","authenticated-orcid":false,"given":"Felix","family":"Boschann","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics and Human Genetics, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , 13353 Berlin ,","place":["Germany"]},{"name":"BIH Biomedical Innovation Academy, BIH Charit\u00e9 (Junior) Clinician Scientist Program, Berlin Institute of Health at Charit\u00e9-Universit\u00e4tsmedizin Berlin , 10178 Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-5013","authenticated-orcid":false,"given":"Ralf","family":"Oheim","sequence":"additional","affiliation":[{"name":"Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-7294","authenticated-orcid":false,"given":"Nicole","family":"Muschol","sequence":"additional","affiliation":[{"name":"International Center for Lysosomal Disorders (ICLD), Department of Pediatrics, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"3","key":"2026052823315177100_ref1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10030161","article-title":"Mucopolysaccharidosis type I","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"19","key":"2026052823315177100_ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911168","article-title":"MPSI manifestations and treatment outcome: skeletal focus","volume":"23","author":"De Ponti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026052823315177100_ref3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2016.01.029","article-title":"Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease","volume":"88","author":"Kingma","year":"2016","journal-title":"Bone"},{"issue":"suppl 5","key":"2026052823315177100_ref4","doi-asserted-by":"publisher","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2026052823315177100_ref5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-8-71","article-title":"Assessment of bone mineral density by dual-energy x-ray absorptiometry in patients with mucopolysaccharidoses","volume":"8","author":"Lin","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2026052823315177100_ref6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00774-021-01304-4","article-title":"Evaluation of bone health in patients with mucopolysaccharidosis","volume":"40","author":"Kor","year":"2022","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"2026052823315177100_ref7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jocd.2022.08.001","article-title":"Radiographic findings of mucopolysaccharidosis and comparison with bone mineral density: a study from Southeastern Turkey","volume":"25","author":"Ayaz","year":"2022","journal-title":"J Clin Densitom"},{"issue":"2","key":"2026052823315177100_ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"2026052823315177100_ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082975","article-title":"Intravenous enzyme replacement therapy in mucopolysaccharidoses: clinical effectiveness and limitations","volume":"21","author":"Parini","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026052823315177100_ref10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","article-title":"Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation","volume":"11","author":"Schmidt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2026052823315177100_ref11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet Med"},{"issue":"5","key":"2026052823315177100_ref12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6760","key":"2026052823315177100_ref13","doi-asserted-by":"publisher","first-page":"eads7373","DOI":"10.1126\/science.ads7373","article-title":"Predicting expression-altering promoter mutations with deep learning","volume":"389","author":"Jaganathan","year":"2025","journal-title":"Science"},{"issue":"1","key":"2026052823315177100_ref14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-017-0733-y","article-title":"Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications","volume":"13","author":"Kuiper","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"2026052823315177100_ref15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","article-title":"Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships","volume":"10","author":"Al-Sannaa","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2026052823315177100_ref16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2026052823315177100_ref17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2026052823315177100_ref18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ajmg.a.63029","article-title":"18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I","volume":"191","author":"Pjetraj","year":"2023","journal-title":"Am J Med Genet A"},{"issue":"Suppl 2","key":"2026052823315177100_ref19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13052-018-0556-z","article-title":"The role of imaging in the skeletal involvement of mucopolysaccharidoses","volume":"44","author":"Spina","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"23","key":"2026052823315177100_ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312651","article-title":"Bone biomarkers in mucopolysaccharidoses","volume":"22","author":"Nakamura-Utsunomiya","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag065\/68023460\/ziag065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/6\/ziag065\/68023460\/ziag065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/6\/ziag065\/68023460\/ziag065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:32:02Z","timestamp":1780025522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag065\/8650974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag065","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,10]]},"article-number":"ziag065"}}